Discover Your Blip. What do you want to watch?
Kirkland's' Daniel Wolf tells The Deal Pipeline about his unique experience in advising Bristol-Myers Squibb in its $2.5 billion acquisition of Inhibitex.
Inside The Deal brings you the latest on business, the economy, mergers and acquisitions and dealmaking.
Discover the best in original web series.
© 2013 Blip Networks, Inc. All Rights Reserved.